-+ 0.00%
-+ 0.00%
-+ 0.00%

GENPREX COLLABORATORS REPORT POSITIVE PRECLINICAL DATA ON THE USE OF REQORSA® GENE THERAPY FOR THE TREATMENT OF RAS INHIBITOR RESISTANT LUNG CANCER AT THE 2025 AACR ANNUAL MEETING

Reuters·04/30/2025 11:30:05

Please log in to view news